BRR : 10289156
Tender Brief : Purchase Of Drugs Tender For Innovator/Original Drugs , Name Of Items : , Abemaciclib , Abemaciclib , Alectinib , Alpelisib , Alteplase , Amivantamab , Asciminib , Atezolizumab , Avelumab , Brentuximab Vedotin , Capecitabine+Cyclophosphamide , Capecitabine+Cyclophosphamide , Capmatinib , Carmustine , Cladribine , Dabrafenib , Dabrafenib , Dacomitinib , Dacomitinib , Daratumumab + Hyaluronidase-Fihj , Darolutamide , Docetaxel Nanosomal(Lipid Suspension) , Docetaxel Nanosomal(Lipid Suspension) , Docetaxel Nanosomal(Lipid Suspension) , Durvalumab , Durvalumab , Enfortumab Vedotin , Enfortumab Ve... Read More
Tender Value
₹
3,20,00,00,000
Submission Date
22-07-2025
Participated Bidder List
32 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | |||||
| 2 | cnet-technologies | Bid Analytics | |||||
| 3 | cnet-technologies | Bid Analytics | |||||
| 4 | cnet-technologies | Bid Analytics | |||||
| 5 | cnet-technologies | Bid Analytics | |||||
| 6 | cnet-technologies | Bid Analytics | |||||
| 7 | cnet-technologies | Bid Analytics | |||||
| 8 | cnet-technologies | Bid Analytics | |||||
| 9 | cnet-technologies | Bid Analytics | |||||
| 10 | cnet-technologies | Bid Analytics | |||||
| 11 | cnet-technologies | Bid Analytics | |||||
| 12 | cnet-technologies | Bid Analytics | |||||
| 13 | cnet-technologies | Bid Analytics | |||||
| 14 | cnet-technologies | Bid Analytics | |||||
| 15 | cnet-technologies | Bid Analytics | |||||
| 16 | cnet-technologies | Bid Analytics | |||||
| 17 | cnet-technologies | Bid Analytics | |||||
| 18 | cnet-technologies | Bid Analytics | |||||
| 19 | cnet-technologies | Bid Analytics | |||||
| 20 | cnet-technologies | Bid Analytics | |||||
| 21 | cnet-technologies | Bid Analytics | |||||
| 22 | cnet-technologies | Bid Analytics | |||||
| 23 | cnet-technologies | Bid Analytics | |||||
| 24 | cnet-technologies | Bid Analytics | |||||
| 25 | cnet-technologies | Bid Analytics | |||||
| 26 | cnet-technologies | Bid Analytics | |||||
| 27 | cnet-technologies | Bid Analytics | |||||
| 28 | cnet-technologies | Bid Analytics | |||||
| 29 | cnet-technologies | Bid Analytics | |||||
| 30 | cnet-technologies | Bid Analytics | |||||
| 31 | cnet-technologies | Bid Analytics | |||||
| 32 | cnet-technologies | Bid Analytics |
Work Detail
purchase of drugs tender for innovator/original drugs , name of items : , abemaciclib , abemaciclib , alectinib , alpelisib , alteplase , amivantamab , asciminib , atezolizumab , avelumab , brentuximab vedotin , capecitabine+cyclophosphamide , capecitabine+cyclophosphamide , capmatinib , carmustine , cladribine , dabrafenib , dabrafenib , dacomitinib , dacomitinib , daratumumab + hyaluronidase-fihj , darolutamide , docetaxel nanosomal(lipid suspension) , docetaxel nanosomal(lipid suspension) , docetaxel nanosomal(lipid suspension) , durvalumab , durvalumab , enfortumab vedotin , enfortumab vedotin , entrectinib , entrectinib , enzalutamide , factor vii eptacog alfa(human recombinant coagulation factor vii activated r-dna origin) , factor vii eptacog alfa(human recombinant coagulation factor vii activated r-dna origin) , fosfestrol , fosnetupitant+palonosetron , gilteritinib , glofitamab , glofitamab , goserelin , goserelin , idarubicin , imatinib , imatinib , inotuzumab , ipilimumab , irinotecan liposomal , isavuconazole , isavuconazole , leuprolide acetate , lorlatinib , lorlatinib , luspatercept , luspatercept , mercaptopurine , meropenem , meropenem , mycobacterium w.(heat killed) immunomodulator , nanosomal paclitaxel lipidsuspension , nanosomal paclitaxel lipidsuspension , nimotuzumab , nintedanib , nintedanib , obinutuzumab , osimertinib , osimertinib , paclitaxel nanoparticle , palanosetron+netupitant(combipack) , panitumumab , pegaspargase , pembrolizumab , pertuzumab+trastuzumab , pertuzumab+trastuzumab , polatuzumab vedotin , ramucirumab , ramucirumab , ribociclib , ruxolitinib , ruxolitinib , ruxolitinib , ruxolitinib , sodium copper chlorophyllin , sodium copper chlorophyllin , teclistamab , teclistamab , tepotinib , thyrotropin alfa , tocilizumab , tocilizumab , tocilizumab , toripalimab , trametinib , trametinib , trastuzumab deruxtecan , tremelimumab , triptorelin , triptorelin , triptorelin , venetoclax , venetoclax , venetoclax , voriconazole , voriconazole , voriconazole
View Original Notice/Document
Result Documents
Tender Documents
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
Financial Evaluation In Progress
Financial bids are currently under review. Awarded bidder information will be published after final evaluation.
PriceBid
Similar Tenders Results